Posaconazole

Journal of Postgraduate Medicine
M BhattacharyaB Dhingra

Abstract

Posaconazole is a novel second-generation Triazole oral antifungal agent. It is highly effective in the prophylaxis of invasive fungal infections in immunocompromised patients. It is used as a first-line agent as well as for salvage therapy in invasive fungal infections including aspergillosis, oropharyngeal and esophageal candidiasis. It has a good adverse effect profile. With the rising incidence of invasive fungal infections due to the HIV pandemic and medical advancements in transplantation and cancer therapy, these features make posaconazole a valuable addition in the family of antifungal agents.

References

Dec 22, 1999·Antimicrobial Agents and Chemotherapy·F BarchiesiG Scalise
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonard B Johnson, Carol A Kauffman
Oct 11, 2003·Lancet·David W Denning
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Philip KrieterRachel Courtney
Sep 3, 2004·Drugs·Helen W BoucherThomas J Walsh
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gregory M AnsteadJohn R Graybill
Sep 2, 2005·The Journal of Antimicrobial Chemotherapy·Punnee PitisuttithumCatherine J Hardalo
Nov 29, 2005·The Lancet Infectious Diseases·Harrys A TorresIssam I Raad
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·R N GreenbergR Hare
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikDimitrios P Kontoyiannis
Apr 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jose A VazquezRandi Isaacs
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issam I RaadDimitrios P Kontoyiannis
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshJohn R Perfect
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel J SkiestRandi Isaacs
Jan 26, 2007·The New England Journal of Medicine·Andrew J UllmannSimon Durrant
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Aug 21, 2008·The Annals of Pharmacotherapy·Erik J RachwalskiMarc H Scheetz
Nov 4, 2008·Current Opinion in Infectious Diseases·William W HopeDavid W Denning
Feb 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan-Willem C AlffenaarDonald R A Uges

❮ Previous
Next ❯

Citations

Aug 7, 2013·Yonsei Medical Journal·Hyo-Jin LeeWoo-Sung Min

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Vijayalakshmi Nagappan, Stan Deresinski
Expert Opinion on Pharmacotherapy
Douglas S Kwon, Eleftherios Mylonakis
Therapeutics and Clinical Risk Management
Stefan LangnerPeter Neumeister
© 2021 Meta ULC. All rights reserved